PAK4 and gastric cancer: At concentrations of higher than 20 μm, this compound effectively suppressed phosphorylation of PAK4 and the proliferation of human gastric cancer cells through downregulation of both PAK4/c-Src/EGFR/cyclinD1 signaling and CDK4/6 expression (Zhang et al., 2016).